Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Retained Earnings (2020 - 2025)

IceCure Medical (ICCM) has disclosed Retained Earnings for 5 consecutive years, with -$105.4 million as the latest value for Q4 2024.

  • On a quarterly basis, Retained Earnings fell 17.01% to -$105.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$105.4 million, a 17.01% decrease, with the full-year FY2024 number at -$105.4 million, down 17.01% from a year prior.
  • Retained Earnings was -$105.4 million for Q4 2024 at IceCure Medical, down from -$90.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$48.5 million in Q4 2020 to a low of -$105.4 million in Q4 2024.
  • A 5-year average of -$75.6 million and a median of -$75.4 million in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: decreased 29.06% in 2022, then fell 17.01% in 2024.
  • IceCure Medical's Retained Earnings stood at -$48.5 million in 2020, then decreased by 20.39% to -$58.4 million in 2021, then fell by 29.06% to -$75.4 million in 2022, then dropped by 19.43% to -$90.1 million in 2023, then dropped by 17.01% to -$105.4 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Retained Earnings are -$105.4 million (Q4 2024), -$90.1 million (Q4 2023), and -$75.4 million (Q4 2022).